samedan logo
 
 
 
spacer
home > ebr > Summer 2011
PUBLICATIONS

European Biopharmaceutical Review

ebr
Summer 2011

   
Text
PDF
BioBusiness, Finance & Communication
IP Strategies

License to Thrill

In the increasingly competitive world of biotechnology, a robust R&D plan needs to have an equally strong IP strategy in place to succeed. With this in mind, Haydn Evans of CPA Global explains the importance of in-licensing.
 
view
download pdf
Drug Repositioning: Small Biotech

An Alternative Path to Drug Discovery

Núria Gavaldà, Núria Reig and Marc Centellas of SOM BIOTECH draw comparisons between multiple drug repurposing case studies, while evaluating the technology platforms and partnering opportunities that could potentially aid these strategies.
 
view
download pdf
Early Stage Drug Discovery

Behind the Screens

Early stage screening offers an affordable way to minimise the possibility of late stage failures. Sandhya Vellore of GBI Research looks at the technologies available for screening potential molecules as well as the latest trends in this market.
 
view
download pdf
bullet
BioResearch and Innovation
Adult Stem Cells

Life and Limb

Bone marrow has been shown to not only be the origin of blood cells, but other types of cells that participate in tissue remodelling and angiogenesis. Ronnda L Bartel, Sharon Watling and Eric Kaldjian at Aastrom Biosciences focus on how bone marrow-derived therapies are being adapted for the lab.
 
view
download pdf
Vaccine Innovation

Implementing Immunostimulants

Frédéric Durmont and Maxence de Villemeur of Lallemand Pharma discuss polyvalent chemical and mechanical bacterial lysates to show how their application affects the oral vaccines market.
 
view
download pdf
bullet
Discovery Technology
Industry Insight: Cell Therapeutics

Finding the Right Place

More sophisticated tools for molecular characterisation and the ability to link this back to the biology involved will be instrumental in delivering full characterisation of the cell, the process and consequently the product, reports Verna McErlane of Sistemic.


 
view
download pdf
BioDiscovery
Therapeutic Antibodies

Novel Libraries

Markus Enzelberger of MorphoSys discusses the impact combinatorial antibody libraries have had on drug discovery and development, and makes predictions about where this technology is going
 
view
download pdf
BioDevelopment
System Control: Data Analysis

Tools of the Trade

Carl-Johan Ivarsson of Qlucore looks at how tools such as principal component analysis and heat maps have provided a powerful way of identifying important structures and patterns, allowing for better comparison of data.
 
view
download pdf
First-in-Man Clinical Trials

Best Laid Plans

Paul
Titley of Aesica, R5 Formulation Development offers tips on reducing the cost of expensive first-time-in-man trials, focusing on the management and evaluation techniques that can help to avoid future wastage.
 
view
download pdf
bullet
BioDevelopment and Regulatory
Non-Clinical Safety Testing

Species Selection

In order to test the safety of new therapeutic mAbs, non-clinical studies have to be carried out using pharmacologically relevant species. Lolke de Haan, Simon Henderson,Mary McFarlane, Alison Scott and Jacintha Shenton of MedImmune analyse the factors involved in determining a species’ relevance to a study.
 
view
download pdf
Assessing Biosimilars

Spot the Difference

With specific reference to international regulations for categorising biosimilars, Shein-Chung Chow of Duke University School of Medicine discusses the fundamentals of biosimilarity and interchangeability.
 
view
download pdf
bullet
BioFormulation and Manufacturing
Phage Production

The Age of Phage

Despite a relative lack of interest in phage biology in the past, researchers are now tapping into the potential of this niche research area.Marcin Los of Phage Consultants considers what we can expect to see from biophages in the future.
 
view
download pdf
Therapeutic Proteins in Plants

Turning a New Leaf

The field of plant-made pharmaceutical therapeutics is hitting a critical point as developers begin looking for regulatory approval. Qiang Shawn Chen of Arizona State University suggests how the future production of biobetters and biosimilars is set to change under the increasing pressure of public perceptions of environmental risk.
 
view
download pdf
Liquid Handling Techniques

Fluid Thinking

Joby Jenkins of TTP LabTech runs a cost:benefit assessment of various liquid handling technologies and runs through methods of minimising the cost of screening through higher throughputs, miniaturising assay formats and streamlining the assay process.
 
view
download pdf
bullet
INTERVIEW
Q&A: Industry Advisors

Biopharm: Past, Present and Future

EBR’s new Industry Advisory Board give their opinions on the current shape of the biotechnology market and how they anticipate it changing in the years to come.
 
view
download pdf
   
spacer


Published quarterly in
January, April,
July, and October

News and Press Releases

New laboratory and regulatory services for biotech customers

USA/Germany, September 21, 2020. Gerresheimer adds essential laboratory and regulatory services to its broad portfolio of products, solutions and services for biotech companies. Specialized laboratory technicians and an experienced team of further specialists offer these services in the two innovation and technology centers in Bünde (Germany) and Vineland (New Jersey/USA). Gx Biological Solutions offers full service for biotech companies regarding product development of primary packaging and drug delivery solutions, material and functional testing as well as comprehensive regulatory support. The partnership with Gerresheimer shortens the time to market for pharmaceutical companies, minimizes risks and saves resources.
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement